Drug recall D-0180-2020
Product
Dr. Reddy's Ranitidine Capsules, USP 300 mg, a.) 30 count bottles (NDC 55111-130-30) b.) 100 count bottles (NDC 55111-130-01)
Reason for recall
CGMP Deviations: Presence of NDMA impurity detected in product.
Lots and codes
Batch Numbers: All lots within expiry.
Recall details
- Recalling firm
- Dr. Reddy's Laboratories, Inc., Princeton, NJ
- Quantity
- N/A
- Distribution
- Product was distributed to major distributors throughout the United States who may have further distributed the product.
- Type
- Voluntary: Firm initiated
- Recall initiated
- October 1, 2019
Related products
- Ranitidine Hydrochloride – drug information
- NDC 55111-130 Ranitidine Hydrochloride · Ranitidine Hydrochloride 300 mg/1 · Dr. Reddy's Laboratories Limited
- NDC 55111-129 Ranitidine Hydrochloride · Ranitidine Hydrochloride 150 mg/1 · Dr. Reddy's Laboratories Limited